Use of Lipid-Lowering Drugs and Associated Outcomes According to Health State Profiles in Hospitalized Older Patients

Carlotta Franchi1 Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, ItalyCorrespondence[email protected]

https://orcid.org/0000-0001-6802-8710

Giulia Lancellotti2 Division of Geriatrics, Department of Biomedical, metabolic and Neural Sciences and Center for Gerontological Evaluation and Research, Università di Modena e Reggio Emilia, Modena, Italy

Marco Bertolotti2 Division of Geriatrics, Department of Biomedical, metabolic and Neural Sciences and Center for Gerontological Evaluation and Research, Università di Modena e Reggio Emilia, Modena, Italy

Simona Di Salvatore2 Division of Geriatrics, Department of Biomedical, metabolic and Neural Sciences and Center for Gerontological Evaluation and Research, Università di Modena e Reggio Emilia, Modena, Italy

Alessandro Nobili1 Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy

Pier Mannuccio Mannucci3 Scientific Direction, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, Italy

https://orcid.org/0000-0002-1915-3897

Chiara Mussi2 Division of Geriatrics, Department of Biomedical, metabolic and Neural Sciences and Center for Gerontological Evaluation and Research, Università di Modena e Reggio Emilia, Modena, Italy

Ilaria Ardoino1 Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy

& On Behalf of the REPOSI (REgistro POliterapie SIMI, Società Italiana di Medicina Interna) Study Group show all

Use of Lipid-Lowering Drugs and Associated Outcomes According to Health State Profiles in Hospitalized Older Patients

Table 1 Patients’ Characteristics at Hospital Admission According to the Health State Profile Identified

Table 2 Results of Logistic Regression Model (or, 95% CI) to Assess the Impact of the Health State Profile and Statin Use, Adjusted for Health State Profile, on Main Clinical Outcomes

Table 3 Results of Logistic Regression Model (or (95% CI)) to Assess the Association Among Diagnosis of Dyslipidemia (A) and Statin Prescription (B) with Cluster Assignment

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Use of Lipid-Lowering Drugs and Associated Outcomes According to Health State Profiles in Hospitalized Older Patients

Figures & data

Table 1 Patients’ Characteristics at Hospital Admission According to the Health State Profile Identified

Table 2 Results of Logistic Regression Model (or, 95% CI) to Assess the Impact of the Health State Profile and Statin Use, Adjusted for Health State Profile, on Main Clinical Outcomes

Table 3 Results of Logistic Regression Model (or (95% CI)) to Assess the Association Among Diagnosis of Dyslipidemia (A) and Statin Prescription (B) with Cluster Assignment

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date